|
(PQ #4) Single cell barcoding for studies of study clonal evolution in glioblasto
|
5R01CA190121-02
|
$332,000
|
$332,000
|
VERHAAK, ROELAND
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
(PQA1) The antipsychotic thioridazine protects against medulloblastoma (MB): volu
|
5R01CA185039-02
|
$373,133
|
$373,133
|
JAN, LILY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
(PQB4) Stochastic Profiling of Functional Single-Cell States Within Solid Tumors
|
1R01CA194470-01
|
$464,569
|
$153,308
|
JANES, KEVIN
|
UNIVERSITY OF VIRGINIA
|
|
(PQB5) Reconstruction of Evolutionary Networks using Cross-Sectional Genomic Data
|
5R01CA185486-02
|
$517,690
|
$258,845
|
RABADAN, RAUL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
(PQB5)Molecular Wiring and Therapeutic Targeting of EGFR and PDGFR Signaling Netw
|
5R01CA185137-02
|
$813,106
|
$813,106
|
CHAREST, ALAIN
|
TUFTS MEDICAL CENTER
|
|
(PQC5) Detecting small clusters of tumor cells with a PTPmu probe
|
5R01CA179956-03
|
$616,995
|
$616,995
|
BRADY-KALNAY, SUSANN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
(PQC5) MRI of magnetically labeled immune/stem cells for early tumor detection
|
5R21CA185163-02
|
$169,558
|
$169,558
|
SHAPIRO, ERIK
|
MICHIGAN STATE UNIVERSITY
|
|
(PQD-5) Patient derived orthotopic xenograft models for drug response prediction
|
5R01CA185402-02
|
$324,033
|
$324,033
|
LI, XIONAN
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQD3) Mechanisms of prolonged initial disease-free survival in glioblastoma
|
5R01CA184320-02
|
$719,226
|
$719,226
|
SARKARIA, JANN
|
MAYO CLINIC ROCHESTER
|
|
(PQD4) MicroRNA Dysregulation in Field Effect is a Prerequisite for Tumorigenesis
|
5R21CA185504-02
|
$232,943
|
$232,943
|
YANG, ZENG-JIE
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
3D-Microtumor_GBM Xenoline Proband Modeling of Kinome-Directed Therapy
|
5R21CA185712-02
|
$159,863
|
$159,863
|
WILLEY, CHRISTOPHER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
A Bayesian Framework for Inter-Modality Deformable Image Registration Evaluation
|
5K01CA181292-03
|
$119,534
|
$29,884
|
CASTILLO, RICHARD
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
|
A causal role for asymmetric cell division defects in glioma initiation
|
5R01CA164746-04
|
$320,588
|
$320,588
|
PETRITSCH, CLAUDIA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
A Mechanistic Understanding of Neuronal Activity Promotion of High-Grade Glioma G
|
1F31CA200273-01
|
$43,120
|
$43,120
|
VENKATESH, HUMSA
|
STANFORD UNIVERSITY
|
|
A Novel Approach to Treating Glioblastoma through Activation of the Liver X Recep
|
5F31CA186668-02
|
$34,837
|
$34,837
|
VILLA, GENARO
|
LUDWIG INSTITUTE FOR CANCER RES LTD
|
|
A novel photopatterning-based paradigm for the study of 3D tumor infiltration
|
5F32CA174361-03
|
$23,571
|
$23,571
|
RAPE, ANDREW
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
A novel strategy to overcome resistance in Temozolomide-Refractory Glioblastomas
|
1R21CA195149-01
|
$179,619
|
$179,619
|
HERGENROTHER, PAUL
|
UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
|
|
A NOVEL TARGETED DELIVERY SYSTEM FOR CANCER TREATMENT AND DIAGNOSIS
|
4R44CA183287-02
|
$1,051,862
|
$1,051,862
|
MURASKI, JOHN
|
ENDURX PHARMACEUTICALS, INC.
|
|
A Phase I Study of CED of Liposomal-Irinotecan using imaging in High Grade Glioma
|
5R21CA186140-02
|
$326,206
|
$326,206
|
BUTOWSKI, NICHOLAS
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
A Phase I Study of Intracranially Administered Carboxylesterase-Expressing Neural
|
1R01CA198076-01
|
$621,329
|
$621,329
|
PORTNOW, JANA
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
A Predictive Prognostic Model for Glioblastoma Multiforme
|
5R01CA157553-04
|
$439,111
|
$439,111
|
BUI, ALEX
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
A Prospective Study of Social Competence in Pediatric Brain Tumor Survivors
|
5K07CA178100-03
|
$130,652
|
$130,652
|
HOCKING, MATTHEW
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196 - 03152
|
$1,131,149
|
$56,557
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-39S1
|
$62,498
|
$1,875
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-39S2
|
$125,000
|
$3,750
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-39
|
$7,704,373
|
$231,131
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Academic-Industrial Partnership to Develop Clinical Brain Cancer Imaging
|
5R01CA166171-03
|
$550,632
|
$550,632
|
ZHOU, JINYUAN
|
JOHNS HOPKINS UNIVERSITY
|
|
Adult Brain Tumor Consortium (ABTC)
|
5UM1CA137443-07
|
$1,999,085
|
$1,999,085
|
GROSSMAN, STUART
|
JOHNS HOPKINS UNIVERSITY
|
|
AIDS Malignancy Consortium (AMC)
|
2UM1CA121947-09
|
$13,134,493
|
$3,283,623
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-02S1
|
$34,176
|
$1,025
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-02S2
|
$810,357
|
$24,311
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-02
|
$9,967,453
|
$299,024
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alternative Mechanisms to Inactivate p53 During Oncogenesis
|
3R01CA156706-06S1
|
$63,867
|
$21,076
|
SHEN, ZHIYUAN
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
Alternative Mechanisms to Inactivate p53 During Oncogenesis
|
5R01CA156706-06
|
$329,925
|
$108,875
|
SHEN, ZHIYUAN
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
An Investigation of Radial Glia as the Source of Ependymoma Stem Cells
|
5R01CA129541-09
|
$162,884
|
$81,442
|
GILBERTSON, RICHARD
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
An investigation of Radial Glia as the source of Ependymoma Stem Cells
|
7R01CA129541-10
|
$159,641
|
$79,821
|
GILBERTSON, RICHARD
|
UNIVERSITY OF CAMBRIDGE
|
|
Analysis of active and inactive EGFR conformations
|
5R01CA112552-10
|
$234,554
|
$117,277
|
FERGUSON, KATHRYN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Analysis of STAG2 Inactivation and Aneuploidy in Human Cancer
|
5R01CA169345-03
|
$322,663
|
$322,663
|
WALDMAN, TODD
|
GEORGETOWN UNIVERSITY
|
|
Angiogenesis-targeting therapy for glioblastoma
|
5R01CA129371-08
|
$575,734
|
$575,734
|
BATCHELOR, TRACY
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Animal Model Development-CAPR infrastructure
|
ZIC BC 011137
|
$1,002,841
|
$100,284
|
Van Dyke, Terry
|
CCR (NCI)
|
|
Annexin A2 as a Novel Enhancer of Tumor-Associated Antigen Processing
|
5F30CA167912-03
|
$48,120
|
$48,120
|
ANDERSEN, BRIAN
|
UNIVERSITY OF MINNESOTA
|
|
Anticancer Drug Pharmacology in Very Young Children
|
5R01CA154619-04
|
$433,475
|
$433,475
|
STEWART, CLINTON
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Apoptotic Proteins as Molecular Modulators of Stem Cell Fate
|
4R00CA178190-03
|
$249,000
|
$249,000
|
GAMA, VIVIAN
|
VANDERBILT UNIVERSITY
|
|
Assaying GBM growth and therapy response in single cells and tumorspheres (PQ17)
|
5R01CA170592-04
|
$489,889
|
$489,889
|
LIGON, KEITH
|
DANA-FARBER CANCER INST
|
|
ATP-Dependent Chromatin Remodeling in Human Malignancy
|
5R01CA163915-04
|
$328,272
|
$82,068
|
CRABTREE, GERALD
|
STANFORD UNIVERSITY
|
|
ATR: a novel therapeutic target for medulloblastoma identified by its role in cer
|
1F30CA192832-01
|
$33,358
|
$33,358
|
LANG, YUN LONG
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Augmented Reality Head Mounted Display for Magnetic Resonance Imaging Guided Inte
|
5R44CA168271-04
|
$463,703
|
$463,703
|
NEVO, EREZ
|
ROBIN MEDICAL, INC.
|
|
Autophagy as a microenvironmental regulator of tumorigenesis and resistance
|
5R01CA188404-02
|
$422,163
|
$422,163
|
DEBNATH, JAYANTA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
B7H1 Mediated Immunosuppression in Glioma
|
5R01CA164714-03
|
$89,360
|
$89,360
|
BLOCH, ORIN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research
|
ZIG BC 010856
|
$14,530,484
|
$726,524
|
Custer, Mary
|
CCR (NCI)
|
Total relevant funding to Brain for this search: $202,158,714
|